MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
3.210
+0.260
+8.81%
After Hours: 3.260 +0.05 +1.56% 19:48 05/14 EDT
OPEN
2.980
PREV CLOSE
2.950
HIGH
3.297
LOW
2.900
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
3.840
52 WEEK LOW
1.620
MARKET CAP
106.15M
P/E (TTM)
-2.4002
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
TipRanks · 11h ago
NRx Pharmaceuticals to report Q1 2026 results, host conference call
PUBT · 19h ago
NRX PHARMACEUTICALS, INC. (NASDAQ:NRXP) TO REPORT FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE
Reuters · 19h ago
NRx Pharmaceuticals initiated with a Buy at Lucid Capital
TipRanks · 1d ago
Weekly Report: what happened at NRXP last week (0504-0508)?
Weekly Report · 3d ago
NRx Pharmaceuticals gets FDA clearance to initiate NRX-101 trial
TipRanks · 05/07 18:39
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
TipRanks · 05/07 18:24
NRx Pharma Receives Clearance From FDA To Initiate Clinical Trial Of NRX-101 Vs. Placebo In Patients With Depression And Suicidality
Benzinga · 05/07 12:13
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.